Clinical Trials on Male Breast Cancer in New Zealand
Total 8792 results
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI)RecruitingAnatomic Stage IV Breast Cancer AJCC v8 | Metastatic Triple-Negative Breast Carcinoma | Unresectable Triple-Negative Breast CarcinomaUnited States
-
Memorial Sloan Kettering Cancer CenterRecruitingBreast Cancer | Breast CarcinomaUnited States
-
Memorial Sloan Kettering Cancer CenterUnited States Department of DefenseActive, not recruitingBreast Cancer | Metastatic HER2-negative BreastUnited States
-
AstraZenecaCompletedBreast Cancer | Bone Neoplasms | Prostate CancerUnited States, United Kingdom, Sweden, Norway, Canada, Portugal, Denmark, Spain
-
NRG OncologyNational Cancer Institute (NCI)SuspendedStage II Breast Cancer | Stage IIIA Breast Cancer | Invasive Breast Carcinoma | Stage IIA Breast Cancer | Stage IIB Breast CancerUnited States, Canada
-
Memorial Sloan Kettering Cancer CenterUniversity of Chicago; New York UniversityActive, not recruitingNon-Metastatic Breast CancerUnited States
-
PfizerAstellas Pharma Inc; Medivation, Inc.Withdrawn
-
SenoRx, Inc.C. R. BardTerminated
-
CelgeneCompletedBreast Cancer | Metastatic Breast Cancer | Stage IV Breast Cancer | Triple-negative Breast Cancer | Recurrent Breast Cancer | Breast Tumor | Cancer of the Breast | Triple-negative Metastatic Breast Cancer | Estrogen Receptor- Negative Breast Cancer | HER2- Negative Breast Cancer | Progesterone Receptor- Negative...United States, United Kingdom, Italy, Germany, Spain, Canada, Portugal, Australia, Austria, Greece, Brazil, France
-
AmgenCompletedCancer | Breast Cancer | Breast Neoplasms | Metastatic Cancer | Breast Tumors | Solid Tumors | Oncology | Tumors | Metastases | Locally Recurrent and Metastatic Breast CancerUnited States, Belgium, France
-
University of Texas Southwestern Medical CenterMerck Sharp & Dohme LLC; Breast Cancer Research FoundationActive, not recruitingBreast Cancer | HER2-positive Breast CancerUnited States
-
German Breast GroupTerminatedMetastatic Breast CancerGermany
-
Weill Medical College of Cornell UniversityRecruiting
-
Memorial Sloan Kettering Cancer CenterPfizer; AmgenCompletedDose-Dense Epirubicin and Cyclophosphamide (EC) Followed by Paclitaxel in Breast Cancer: FeasibilityBreast Cancer | Adenocarcinoma of the BreastUnited States
-
Memorial Sloan Kettering Cancer CenterRecruitingBreast CancerUnited States
-
Proton Collaborative GroupRecruiting
-
Columbia UniversityNational Cancer Institute (NCI)Recruiting
-
NYU Langone HealthRecruitingBreast CancerUnited States
-
PfizerActive, not recruiting
-
PfizerCompleted
-
Icahn School of Medicine at Mount SinaiNational Institute on Minority Health and Health Disparities (NIMHD)CompletedBreast CancerUnited States
-
Memorial Sloan Kettering Cancer CenterMARTELL FOUNDATIONActive, not recruiting
-
PfizerTerminatedBreast CancerUnited States
-
Memorial Sloan Kettering Cancer CenterUniversity of Washington; Sarah Lawrence CollegeCompletedBreast CancerUnited States
-
NYU Langone HealthCompletedBreast CancerUnited States
-
NYU Langone HealthCompletedBreast CancerUnited States
-
NYU Langone HealthCompleted
-
NYU Langone HealthTerminatedBreast CancerUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedBreast CancerUnited States
-
Memorial Sloan Kettering Cancer CenterGE HealthcareCompletedBreast CancerUnited States
-
Memorial Sloan Kettering Cancer CenterCompleted
-
Memorial Sloan Kettering Cancer CenterTerminatedBreast CancerUnited States
-
Columbia UniversityGlaxoSmithKlineTerminated
-
NYU Langone HealthNovartis PharmaceuticalsCompleted
-
Memorial Sloan Kettering Cancer CenterRalph Lauren Center for Cancer Care and Prevention; North General Hospital,...CompletedBreast CancerUnited States
-
NYU Langone HealthNational Cancer Institute (NCI)Completed
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedBreast CancerUnited States
-
Weill Medical College of Cornell UniversityCompleted
-
Roswell Park Cancer InstituteAstraZeneca; National Center for Complementary and Integrative Health (NCCIH)Completed
-
Memorial Sloan Kettering Cancer CenterJohns Hopkins University; University of British Columbia; University of Pittsburgh and other collaboratorsCompletedBreast Surgery | Breast Cancer | Breast Augmentation | Breast Reconstruction | Breast ReductionUnited States, Canada
-
PfizerTerminatedAdvanced Breast CancerUnited States, Hungary, Spain, Belgium, China, Hong Kong, Australia, Poland, Canada, India, South Africa
-
National Cancer Institute (NCI)Eastern Cooperative Oncology Group; Canadian Cancer Trials Group; Southwest Oncology... and other collaboratorsCompletedHER2 Positive Breast Carcinoma | Stage IA Breast Cancer AJCC v7 | Stage IB Breast Cancer AJCC v7 | Stage IIA Breast Cancer AJCC v6 and v7 | Stage IIB Breast Cancer AJCC v6 and v7 | Stage IIIA Breast Cancer AJCC v7 | Breast AdenocarcinomaUnited States, Canada, Peru, South Africa
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingAnatomic Stage IV Breast Cancer AJCC v8 | Prognostic Stage IV Breast Cancer AJCC v8 | Hormone Receptor Positive Breast Carcinoma | Metastatic Breast CarcinomaUnited States
-
Oana DanciuNovartis PharmaceuticalsRecruitingHER2-negative Breast Cancer | Locoregional Recurrence | Hormone Receptor-positive Breast CancerUnited States
-
US Oncology ResearchBristol-Myers Squibb; PfizerActive, not recruiting
-
German Breast GroupCompletedMetastatic Breast CancerGermany
-
Memorial Sloan Kettering Cancer CenterRecruitingBreast CancerUnited States
-
Memorial Sloan Kettering Cancer CenterActive, not recruiting
-
Memorial Sloan Kettering Cancer CenterUniversity of Pennsylvania; Genentech, Inc.CompletedBreast CancerUnited States
-
Memorial Sloan Kettering Cancer CenterAmgenCompleted